Compensation award — excluded from discretionary-purchase analysis.
Traded Oct 28, 2025 · Filed Oct 31, 2025
A board member of Oracle sold $2.55M of Oracle shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$2,546,037
Shares × reported transaction price
49 days after results of Sep 9, 2025, 43 days before results of Dec 10, 2025
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $280.83 on Oct 28, 2025, 129% above its 52-week low and 14% below its high, after an 8% drop over the previous 30 trading days
52-week range $122.82 (Apr 21, 2025) to $328.33 (Sep 10, 2025), 77% of the way up, from 250 adjusted closes. 30 trading days earlier: $306.65 on Sep 16, 2025. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | -8.9% | -1.6% | -7.3% |
| 30 days | -23.5% | -0.3% | -23.2% |
| 90 days | -35.6% | +1.8% | -37.4% |
| 180 days | -37.6% | +4.3% | -41.9% |
Past results only. Not a forecast.
Compensation award — excluded from discretionary-purchase analysis.
7 different filers disclosed ORCL within 90 days. Disclosed 21 days after the transaction; reported as an official range, not an exact amount.
7 different filers disclosed ORCL within 90 days. Disclosed 22 days after the transaction; reported as an official range, not an exact amount.